{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:58:44Z","timestamp":1790269124044,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T00:00:00Z","timestamp":1630713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00428-021-03184-5","type":"journal-article","created":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T21:02:21Z","timestamp":1630789341000},"page":"1121-1126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Indolent T-lymphoblastic proliferation: a report of three cases"],"prefix":"10.1007","volume":"480","author":[{"given":"Zheng","family":"Yuanyuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Jianlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Yanlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Xiaoge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,4]]},"reference":[{"key":"3184_CR1","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/00000478-199908000-00017","volume":"23","author":"MM Velankar","year":"1999","unstructured":"Velankar MM, Nathwani BN, Schlutz MJ, Bain LA, Arber DA, Slovak ML, Weiss LM (1999) Indolent T-lymphoblastic proliferation: report of a case with a 16-year course without cytotoxic therapy. Am J Surg Pathol 23:977\u2013981. https:\/\/doi.org\/10.1097\/00000478-199908000-00017","journal-title":"Am J Surg Pathol"},{"key":"3184_CR2","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1097\/pas.0b013e318264e223","volume":"36","author":"RS Ohgami","year":"2012","unstructured":"Ohgami RS, Zhao S, Ohgami JK, Leavitt MO, Zehnder JL, West RB, Arber DA, Natkunam Y, Warnke RA (2012) TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 36:1619\u20131628. https:\/\/doi.org\/10.1097\/pas.0b013e318264e223","journal-title":"Am J Surg Pathol"},{"key":"3184_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/10428190802645079","volume":"50","author":"YW Qian","year":"2009","unstructured":"Qian YW, Weissmann D, Goodell L, August D, Strair R (2009) Indolent T-lymphoblastic proliferation in Castleman lymphadenopathy. Leuk Lymphoma 50:306\u2013308. https:\/\/doi.org\/10.1080\/10428190802645079","journal-title":"Leuk Lymphoma"},{"key":"3184_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4132\/jptm.2014.11.17","volume":"49","author":"CG Woo","year":"2015","unstructured":"Woo CG, Huh J (2015) TdT+ T-Lymphoblastic proliferation in Castleman disease. J Pathol Transl Med 49:1\u20134. https:\/\/doi.org\/10.4132\/jptm.2014.11.17","journal-title":"J Pathol Transl Med"},{"key":"3184_CR5","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.humpath.2015.03.007","volume":"46","author":"R Kansal","year":"2015","unstructured":"Kansal R, Nathwani BN, Yiakoumis X, Moschogiannis M, Sachanas S, Stefanaki K, Pangalis GA (2015) Exuberant cortical thymocyte proliferation mimicking T-lymphoblastic lymphoma within recurrent large inguinal lymph node masses of localized Castleman disease. Hum Pathol 46:1057\u20131061. https:\/\/doi.org\/10.1016\/j.humpath.2015.03.007","journal-title":"Hum Pathol"},{"key":"3184_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.annpat.2018.09.003","volume":"39","author":"B Chauveau","year":"2019","unstructured":"Chauveau B, Le Loarer F, Bacci J, Baylac F, Dubus P, Ling C, Parrens M (2019) Indolent T-lymphoblastic proliferation in association with localized Castleman disease: a case report. Ann Pathol 39:29\u201335. https:\/\/doi.org\/10.1016\/j.annpat.2018.09.003","journal-title":"Ann Pathol"},{"key":"3184_CR7","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1097\/pas.0000000000001158","volume":"42","author":"M Walters","year":"2018","unstructured":"Walters M, Pittelkow MR, Hasserjian RP, Harris NL, Macon WR, Kurtin PJ, Rech KLG (2018) Follicular dendritic cell sarcoma with indolent T-lymphoblastic proliferation is associated with paraneoplastic autoimmune multiorgan syndrome. Am J Surg Pathol 42:1647\u20131652. https:\/\/doi.org\/10.1097\/pas.0000000000001158","journal-title":"Am J Surg Pathol"},{"key":"3184_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pathol.2017.09.017","volume":"50","author":"AE Quesada","year":"2018","unstructured":"Quesada AE, Young KH, Medeiros LJ, Thakral B (2018) Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and Castleman disease. Pathology 50:351\u2013352. https:\/\/doi.org\/10.1016\/j.pathol.2017.09.017","journal-title":"Pathology"},{"key":"3184_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/00000478-200103000-00018","volume":"25","author":"JA Strauchen","year":"2001","unstructured":"Strauchen JA (2001) Indolent T-lymphoblastic proliferation: report of a case with an 11-year history and association with myasthenia gravis. Am J Surg Pathol 25:411\u2013415","journal-title":"Am J Surg Pathol"},{"key":"3184_CR10","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1097\/pas.0000000000000197","volume":"38","author":"RS Ohgami","year":"2014","unstructured":"Ohgami RS, Sendamarai AK, Atwater SK, Liedtke M, Fleming MD, Natkunam Y, Warnke RA (2014) Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression. Am J Surg Pathol 38:1298\u20131304. https:\/\/doi.org\/10.1097\/pas.0000000000000197","journal-title":"Am J Surg Pathol"},{"key":"3184_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/pas.0000000000000197","volume":"20","author":"RS Ohgami","year":"2013","unstructured":"Ohgami RS, Arber DA, Zehnder JL, Natkunam Y, Warnke RA (2013) Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma. Adv Anat Pathol 20:137\u2013140. https:\/\/doi.org\/10.1097\/pas.0000000000000197","journal-title":"Adv Anat Pathol"},{"key":"3184_CR12","first-page":"407","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"A Dogan","year":"2017","unstructured":"Dogan A, Gaulard P, Jaffe ES, M\u00fcller-Hermelink HK, de Leval L (2017) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, pp 407\u2013412"},{"key":"3184_CR13","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1182\/blood-2009-08-231217","volume":"114","author":"DI Marks","year":"2009","unstructured":"Marks DI, Paietta EM, Moorman AV, Richards SM, Buck G, DeWald G, Ferrando A, Fielding AK, Goldstone AH, Ketterling RP, Litzow MR, Luger SM, McMillan AK, Mansour MR, Rowe JM, Tallman MS, Lazarus HM (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial. Blood 114:5136\u20135145. https:\/\/doi.org\/10.1182\/blood-2009-08-231217","journal-title":"Blood"},{"key":"3184_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ajcp\/aqv024","volume":"45","author":"D Jevremovic","year":"2016","unstructured":"Jevremovic D, Roden AC, Ketterling RP, Kurtin PJ, McPhail ED (2016) LMO2 is a specific marker of T-lymphoblastic leukemia\/lymphoma. Am J Clin Pathol 45:180\u2013190. https:\/\/doi.org\/10.1093\/ajcp\/aqv024","journal-title":"Am J Clin Pathol"},{"key":"3184_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2559.2012.04198.x","volume":"61","author":"C Agostinelli","year":"2012","unstructured":"Agostinelli C, Paterson JC, Gupta R, Righi S, Sandri F, Piccaluga PP, Bacci F, Sabattini E, Pileri SA, Marafioti T (2012) Detection of LIM domain only 2 (LMO2) in normal human tissues and haematopoietic and non-haematopoietic tumours using a newly developed rabbit monoclonal antibody. Histopathology 61:33\u201346. https:\/\/doi.org\/10.1111\/j.1365-2559.2012.04198.x","journal-title":"Histopathology"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-021-03184-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-021-03184-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:08:29Z","timestamp":1650604109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-021-03184-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,4]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3184"],"URL":"https:\/\/doi.org\/10.1007\/s00428-021-03184-5","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,4]]},"assertion":[{"value":"16 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent for use of tissue samples for research and were audited by the Medical Ethics Committee of Beijing Friendship Hospital, Capital Medical University (approval number 2020-P2-137\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}